epigenetics market
Healthcare

Global epigenetics market expected to be driven by increasing prevalence of cancer and other diseases in next 10 years

Epigenetics is the study of heritable changes in gene expression. It is a process that alter gene activities without changing the DNA sequence. Increasing number of research activities for epigenetics in developed and developing economics is expected to drive the market growth. Technological innovations in the testing methods is expected to propel the market growth. Rising government investment and increasing number of cases for cancer and other diseases is expected to support the market growth. However, lack of trained professional is limiting growth factor for global epigenetics market.

Based on application, the market is segment based on oncology, and non oncology. The oncology segment contributes major market share and is expected to maintain its dominance over the forecast period owing to the increasing prevalence of cancer globally and introduction of new products in the market.

Based on end user, the market is segmented based on academic and research institutes, pharmaceutical and biotechnology companies, and contract research organizations. The academic and research institutes segment contributes major market share owing to favorable government initiatives and increasing number of research activities.

Do Inquiry of the Report Here: https://marketresearch.biz/report/epigenetics-market/#inquiry

Based on region, the global epigenetics market is segmented into North America, Europe, Latin America, Asia Pacific and Middle East and Africa. North America contributes major market share and expected to maintain its dominance over the forecast period owing to well-developed health infrastructure, favorable government initiatives and increasing number of research activities for epigenetics. Asia Pacific is expected to witness rapid growth rate over the forecast period. This is attributed to the increasing prevalence cancer and other diseases.

Some prominent players in the global epigenetics market are Bio-Rad Laboratories, Inc., Thermo Fisher Scientific Inc., Diagenode, QIAGEN, Abcam Plc., New England Biolabs, Agilent Technologies, Zymo Research, PerkinElmer, Inc., and Active Motif.

 

Get Free Sample Copy

captcha

%d bloggers like this: